Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Head & Neck 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 36 Melphalan 29 Cyclophosphamide 28 Specimen Handling 26 Biopsy 26 Bortezomib 24 Calcium Dobesilate 20 Magnetic Resonance Spectroscopy 19 Lenalidomide 17 fludarabine phosphate 15 Filgrastim 15 Peripheral Blood Stem Cell Transplantation 13 Vincristine 12 Prednisone 12 dexamethasone acetate 11 dexamethasone 21-phosphate 11 auricularum 11 carfilzomib 10 Doxorubicin 10 sargramostim 9 fludarabine 8 Thalidomide 8 Interferon-alpha 7 Cyclosporine 7 Busulfan 7 trametinib 6 ixazomib 6 Rituximab 6 Etoposide 6 daratumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × fluciclovine F-18 × Plasma cell × Clear all

NCT06103838 2026-05-29

18F-Fluciclovine PET/CT in Multiple Myeloma

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡